Asset Details
Do you wish to reserve the book?
A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors
Do you wish to request the book?
A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors
2022
Overview
Multitarget datasets that correlate bioactivity landscapes of small-molecules toward different related or unrelated pharmacological targets are crucial for novel drug design and discovery. ATP-binding cassette (ABC) transporters are critical membrane-bound transport proteins that impact drug and metabolite distribution in human disease as well as disease diagnosis and therapy. Molecular-structural patterns are of the highest importance for the drug discovery process as demonstrated by the novel drug discovery tool ‘computer-aided pattern analysis’ (‘C@PA’). Here, we report a multitarget dataset of 1,167 ABC transporter inhibitors analyzed for 604 molecular substructures in a statistical binary pattern distribution scheme. This binary pattern multitarget dataset (ABC_BPMDS) can be utilized for various areas. These areas include the intended design of (i) polypharmacological agents, (ii) highly potent and selective ABC transporter-targeting agents, but also (iii) agents that avoid clearance by the focused ABC transporters [e.g., at the blood-brain barrier (BBB)]. The information provided will not only facilitate novel drug prediction and discovery of ABC transporter-targeting agents, but also drug design in general in terms of pharmacokinetics and pharmacodynamics.Measurement(s)Influx • Efflux • Tracer • Transport velocityTechnology Type(s)Fluorometry • Radioactivity • Plate reader • Flow cytometer • Tracer distributionFactor Type(s)half-maximal inhibition concentrationSample Characteristic - OrganismHomo sapiensSample Characteristic - Environmentcell cultureSample Characteristic - LocationKingdom of Norway • Germany • Australia • Latvia
Publisher
Nature Publishing Group
